PLoS ONE (Jan 2014)

Dicer regulates differentiation and viability during mouse pancreatic cancer initiation.

  • John P Morris,
  • Renee Greer,
  • Holger A Russ,
  • Guido von Figura,
  • Grace E Kim,
  • Anke Busch,
  • Jonghyeob Lee,
  • Klemens J Hertel,
  • Seung Kim,
  • Michael McManus,
  • Matthias Hebrok

DOI
https://doi.org/10.1371/journal.pone.0095486
Journal volume & issue
Vol. 9, no. 5
p. e95486

Abstract

Read online

miRNA levels are altered in pancreatic ductal adenocarcinoma (PDA), the most common and lethal pancreatic malignancy, and intact miRNA processing is essential for lineage specification during pancreatic development. However, the role of miRNA processing in PDA has not been explored. Here we study the role of miRNA biogenesis in PDA development by deleting the miRNA processing enzyme Dicer in a PDA mouse model driven by oncogenic Kras. We find that loss of Dicer accelerates Kras driven acinar dedifferentiation and acinar to ductal metaplasia (ADM), a process that has been shown to precede and promote the specification of PDA precursors. However, unconstrained ADM also displays high levels of apoptosis. Dicer loss does not accelerate development of Kras driven PDA precursors or PDA, but surprisingly, we observe that mouse PDA can develop without Dicer, although at the expense of proliferative capacity. Our data suggest that intact miRNA processing is involved in both constraining pro-tumorigenic changes in pancreatic differentiation as well as maintaining viability during PDA initiation.